Covered recipient · General Payments record
ADRIANNE R POWELL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$556.03
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.09 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $164.92 | 3 |
| Lilly USA, LLC | $85.10 | 4 |
| Corcept Therapeutics | $22.49 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.87 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $14.87 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086245084 | CMS |
| Corcept Therapeutics | $22.49 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117775516 | CMS |
| Lilly USA, LLC | $23.46 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136009251 | CMS |
| Lilly USA, LLC | $18.48 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136004125 | CMS |
| Lilly USA, LLC | $17.78 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136008197 | CMS |
| Lilly USA, LLC | $25.38 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136010635 | CMS |
| Novo Nordisk Inc | $22.72 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097325137 | CMS |
| Novo Nordisk Inc | $121.86 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096745703 | CMS |
| Novo Nordisk Inc | $20.34 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097387678 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.71 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153577375 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.